DONDI, DONATELLA
 Distribuzione geografica
Continente #
EU - Europa 5.239
NA - Nord America 4.172
AS - Asia 3.803
SA - Sud America 299
AF - Africa 80
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 5
Totale 13.611
Nazione #
US - Stati Uniti d'America 4.055
GB - Regno Unito 1.970
SG - Singapore 1.186
CN - Cina 1.136
DE - Germania 865
SE - Svezia 518
IT - Italia 466
RU - Federazione Russa 401
HK - Hong Kong 282
VN - Vietnam 244
BD - Bangladesh 228
FR - Francia 220
NL - Olanda 217
TR - Turchia 213
BR - Brasile 194
KR - Corea 167
UA - Ucraina 164
IE - Irlanda 134
IN - India 126
FI - Finlandia 107
EU - Europa 102
CA - Canada 64
CO - Colombia 41
JP - Giappone 36
PH - Filippine 36
CI - Costa d'Avorio 31
ID - Indonesia 30
GR - Grecia 29
IQ - Iraq 28
MX - Messico 22
ES - Italia 19
BE - Belgio 17
AR - Argentina 16
PL - Polonia 16
DK - Danimarca 15
RO - Romania 14
ZA - Sudafrica 14
CL - Cile 12
TW - Taiwan 12
AU - Australia 11
CH - Svizzera 11
SA - Arabia Saudita 10
UY - Uruguay 10
AT - Austria 9
IL - Israele 9
EC - Ecuador 8
MY - Malesia 8
PK - Pakistan 8
AE - Emirati Arabi Uniti 7
ET - Etiopia 7
JM - Giamaica 7
NO - Norvegia 7
PT - Portogallo 7
UZ - Uzbekistan 7
VE - Venezuela 7
RS - Serbia 6
CR - Costa Rica 5
HR - Croazia 5
HU - Ungheria 5
JO - Giordania 5
PA - Panama 5
CZ - Repubblica Ceca 4
EG - Egitto 4
PY - Paraguay 4
TH - Thailandia 4
BG - Bulgaria 3
BO - Bolivia 3
CW - ???statistics.table.value.countryCode.CW??? 3
HN - Honduras 3
IR - Iran 3
KE - Kenya 3
NP - Nepal 3
PE - Perù 3
SN - Senegal 3
AO - Angola 2
CG - Congo 2
DZ - Algeria 2
EE - Estonia 2
GT - Guatemala 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MA - Marocco 2
MN - Mongolia 2
MU - Mauritius 2
NG - Nigeria 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BJ - Benin 1
BZ - Belize 1
CU - Cuba 1
CV - Capo Verde 1
CY - Cipro 1
Totale 13.695
Città #
Southend 1.847
Singapore 616
Hanover 379
Ashburn 358
Chandler 349
Seattle 274
Hong Kong 268
San Jose 235
Beijing 223
Princeton 172
Milan 165
Dallas 158
Santa Clara 149
Wilmington 142
Dublin 132
Council Bluffs 126
Redmond 126
Jacksonville 117
New York 115
Ann Arbor 113
Los Angeles 97
Woodbridge 97
Fairfield 92
Frankfurt am Main 86
Nanjing 82
Ho Chi Minh City 78
Sakarya 78
Lauterbourg 69
Des Moines 68
Mountain View 67
Boardman 62
Moscow 58
Munich 57
Buffalo 55
Dearborn 55
Guangzhou 54
Houston 51
Shanghai 50
Bengaluru 47
Hanoi 46
Toronto 45
Shenyang 43
Somerville 42
Andover 40
Cambridge 38
Bogotá 35
Jinan 33
Abidjan 31
Athens 29
Zhengzhou 29
Tokyo 28
Grafing 26
Norwalk 26
Cangzhou 25
Tianjin 25
Redwood City 24
Changsha 23
Nanchang 23
Rome 23
Serra 23
Helsinki 22
The Dalles 22
Bitonto 21
Hangzhou 21
Medford 21
São Paulo 21
Mannheim 20
Columbus 19
Hefei 19
Da Nang 18
Jakarta 18
San Diego 18
Lanzhou 17
Ningbo 16
Turin 16
Berlin 15
Brussels 15
Kiez 15
Hebei 14
Jiaxing 14
Fuzhou 13
Istanbul 12
Phoenix 12
Roxbury 12
Haikou 11
London 11
Warsaw 11
Haiphong 10
Sunnyvale 10
Taizhou 10
Auburn Hills 9
Baghdad 8
Belo Horizonte 8
Dhaka 8
Montevideo 8
Seoul 8
Atlanta 7
Denver 7
Kuala Lumpur 7
Naples 7
Totale 8.575
Nome #
The luteinizing hormone-releasing hormone receptor in human prostate cancer cells: messenger ribonucleic acid expression, molecular size, and signal transduction pathway 443
Expression and differential effects of the activation of glucocorticoid receptors in mouse gonadotropin-releasing hormone neurons 340
Antiproliferative effect of mifepristone ({RU}486) on human neuroblastoma cells ({SK}-N-{SH}): in vitro and in vivo studies 322
suPAR, a soluble form of urokinase plasminogen activator receptor, inhibits human prostate cancer cell growth and invasion 320
Estrogen receptor β and the progression of prostate cancer : role of 5{alpha}-androstane-3β,17β-diol 317
Luteinizing hormone-releasing hormone agonists interfere with the mitogenic activity of the insulin-like growth factor system in androgen-independent prostate cancer cells 270
Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145: evidence for an autocrine-inhibitory LHRH loop 268
Biologia Cellulare 267
Effects of caloric restriction and low glycemic index diets associated with metformin on glucose metabolism and cortisol response in overweight/obese subjects: a case series study 243
Estrogen receptor beta and the progression of prostate cancer - role of 5alpha-androstane-3beta,17beta-diol (3beta-Adiol) 238
Ageing of the neuroendocrine system in the brain of male rats: receptor mechanisms and steroid metabolism 223
Aging and the hypothalamo-pituitary-testicular axis in the rat 204
Role of glucocorticoids in the migration of immature LHRH neurons 194
Endocrinology of aging 194
Binding characteristics of hypothalamic mu opioid receptors throughout the estrous cycle in the rat 193
Role of a soluble form of urokinase plasminogen-activator receptor in the control of human prostate cancer cell growth and invasion 191
Antiproliferative action of RU486 on human neuroblastoma cells (SK-N-SH) 187
Role of Estrogen Receptor beta on prostate cancer cell migration 186
Effect of oestrus cyclicity on the number of brain opioid mu receptors in the rat 186
Characterization of prostate cancer DU145 cells expressing the recombinant androgen receptor 185
Role of estrogen receptor beta in the progression of prostate cancer 184
Characterization of a soluble LHRH-degrading activity in the rat ventral prostate 182
Role of growth factors, steroid and peptide hormones in the regulation of human prostatic tumor growth 182
Ozarelix, a fourth generation GnRH antagonist, induces apoptosis in hormone refractory androgen receptor negative prostate cancer cells modulating expression and activity of death receptors 179
Androgen-dependent prostatic tumors: biosynthesis and possible actions of LHRH 179
Effects of aging on pituitary and testicular luteinizing hormone-releasing hormone receptors in the rat 177
Expression and role of glucocorticoid receptors in mouse neurons secretine gonadotropin releasing hormons 176
Dexamethasone blocks the migration of the human neuroblastoma cell line SK-N-SH 176
Cellular mechanisms regulating uPA in hormone refractory prostate cancer : role of suPAR, a solubile form of Urokinase Plasminogen-Activator Receptor 175
Regolazione del sistema attivatore del plasminogeno da parte degli ormoni glucocorticoidi nella progressione metastatica del cancro prostatico 173
Decrease of mu opioid receptors in the brain and in the hypothalamus of the aged male rat 172
Role of Ozarelix in the control of proliferation, migration and invasion of human prostate cancer cell lines 171
Antiproliferative action of melatonin on human prostate cancer LNCaP cells 171
GnRH agonists and antagonists decrease the metastatic progression of human prostate cancer cell lines by inhibiting the plasminogen activator system 170
Antiproliferative effects of luteinizing hormone-releasing hormone agonists on the human prostatic cancer cell line LNCaP 170
Effect of aging on opioid and LHRH receptors in the brain, pituitary, and testis of the male rat 170
Hypothalamic ß-endorphin and brain mu opiate receptor concentrations in male rat after restraint stress 165
Endocrine responses to naloxone in young and old male rats. 165
Role of estrogen receptor β in the pathogenesis and progression of prostate cancer 164
Dexamethasone modulates differentiation and motility of SK-N-SH human neuroblastoma cells 163
Dosimetric analysis of phenolic solid state pellets exposed to radio-therapeutic photon and electron beams through electron spin resonance technique=Analisi dosimetrica di composti fenolici irradiati con fasci clinici di fotoni ed elettroni tramite spettroscopia di risonanza di spin elettronico 163
In vivo growth properties and molecular marker expression of DU145 human prostate tumor cells expressing recombinant androgen receptor 162
Dexamethasone blocks the migration of the human neuroblastoma cell line SK-N-SH 162
Testosterone and postnatal ontogenesis of hypothalamic mu ([3H]dihydromorphine) opioid receptors in the rat 160
Biology of hypothalamic neurons producing gonadotropin-releasing hormone (GnRH): new information on the use of immortalized cells secreting GnRH 158
Expression and role of functional glucocorticoid receptors in the human androgen-independent prostate cancer cell line, DU145 154
Binding characteristics of delta opioid receptors in different regions of the brain of young and old male rats as studied with the highly selective ligand [D-Pen2-D-Pen5] enkephalin 154
Gonadal steroid modulation of brain opioid systems 152
Growth of the androgen-dependent tumor of the prostate: role of androgens and of locally expressed growth modulatory factors 151
Effetto degli analoghi del GnRH sul sistema attivatore del plasminogeno nella progressione metastatica del cancro prostatico umano 149
Comments on inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II, Jungwirth et al., Eur J Cancer 1997, 33(7), 1141-1148 149
Modulation by sex steroids of brain opioid receptors: implications for the control of gonadotropins and prolactin secretion 147
Growth factors in steroid-responsive prostatic tumor cells 146
The metastatic progression of prostate cancer effect of LHRH analogs on plasminogen activator system 144
Involvment of the glucocorticoid receptor in the migration of GN11 LHRH neurons 144
Morphine stimulates prolactin release in normal but not in castrated male rats 143
Distribution of kappa opioid receptors in the brain of young and old male rats 143
La progressione metastatica del cancro prostatico umano: effetto degli analoghi del GnRH sul sistema attivatore del plasminogeno 141
LRHR as a growth-inhibitory factor in prostatic tumor cells: possible mechanism of action 141
The EGF/TGFalpha system as an autocrine growth stimulatory loop in LNCaP cells 141
Effect of glucocorticoids on the plasminogen activator system in the metastatic progression of prostate cancer 140
Involvment of Glucocorticoid receptors in the migratore activity of immortalized GnRH secreting neurons 137
Meccanismo d'azione degli ormoni 135
Effect of LHRH analogs on the Urokinase Receptor in the metastatic progression of prostate cancer 135
Growth-inhibitory effects of luteinizing hormone-releasing hormone (LHRH) agonists on xenografts of the DU 145 human androgen-independent prostate cancer cell line in nude mice 135
Luteinizing hormone-releasing hormone agonists interfere with the stimulatory actions of epidermal growth factor in human prostatic cancer cell lines, LNCaP and DU 145 135
Modulation of the binding characteristics of hypothalamic mu opioid receptors in rats by gonadal steroids 134
Epigenetic control of pi3k/akt activity in prostate cancer during hormone manipulation 134
Soluble urokinase-type plasminogen activation receptor inhibits prostate cancer cell growth and invasion 131
GnRH analogues inhibit the plasminogen activator system and the metastatic progression of prostate cancer 131
Peptide-steroid interactions in the modulation of the hypothalamic-pituitary axis 130
Neonatal organization of the brain opioid systems controlling prolactin and luteinizing hormone secretion 130
Hypothalamic opiatergic tone during pregnancy, parturition and lactation in the rat 130
Sex steroids and brain opioid receptors 128
The metastatic progression of prostate cancer : effect of LHRH analogs on plasminogen activator system 126
Further evidence that gonadal steroids do not modulate brain opiate receptors in male rats 126
Effects of steroids on the brain opioid system 126
Expression of luteinizing hormone-releasing hormone mRNA in the human prostatic cancer cell line LNCaP 124
Role of GnRH analogs in the control of the plasminogen activator system in human prostate cancer cell lines 121
Effect of ovarian steroids on the concentration of mu opiate receptors in different regions of the brain of the female rat 113
Effetto degli analoghi dell’LHRH sul sistema attivatore del plasminogeno nella progressione metastatica del cancro prostatico umano” 107
Mechanism of action of interleukin-1 in modulating gonadotropin secretion. In vivo and in vitro studies 101
Effects of ovarian hormones on brain opioid binding sites in castrated female rats 93
Totale 14.341
Categoria #
all - tutte 35.717
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.717


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202198 0 0 0 0 0 0 0 0 0 0 0 98
2021/20221.276 77 19 121 60 104 67 73 88 214 112 140 201
2022/20231.173 138 85 96 142 146 234 28 123 90 7 72 12
2023/2024686 25 62 35 41 201 44 25 32 5 11 102 103
2024/20251.694 55 101 15 149 172 75 49 187 81 198 114 498
2025/20263.568 362 162 348 208 354 220 410 180 402 325 348 249
Totale 14.341